GlobeNewswire Inc | Oct 19, 2020 03:24PM EDT

October 19, 2020

WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of fiduciary duties and other violations of law related to Eidos agreement to be acquired by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-eidos-therapeutics-inc.

American Renal Associates Holdings, Inc. (NYSE: ARA) regarding possible breaches of fiduciary duties and other violations of law related to American Renal Associates agreement to be acquired by affiliates of Nautic Partners, LLC. Under the terms of the agreement American Renal Associates shareholders will receive $11.50 per share in cash. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-american-renal-associates-holdings-inc.

MVC Capital, Inc. (NYSE: MVC) regarding possible breaches of fiduciary duties and other violations of law related to MVC Capitals agreement to be acquired by Barings BDC, Inc. Under the terms of the agreement MVC Capitals shareholders will receive $0.39492 in cash and 0.94024 of a share of Barings BDC per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-mvc-capital-inc.

Cancer Genetics, Inc. (NASDAQ CM: CGIX) regarding possible breaches of fiduciary duties and other violations of law related to Cancer Genetics agreement to merge with StemoniX, Inc. Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cancer-genetics-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com